Abciximab antithrombotics
systematic review meta-analysis network meta-analysis
 

     

Select             pdf
Filter

  • Group by...
Trial Studied trt Control trt patientstagsROB Trial resultMajor bleedingAll cause death

acute myocardial infarction  

BRAVE (Kastrati), 2004     Abciximab + reteplaseprimary intervention -
ERAMI (Mesquita Gabriel), 2003   Abciximabprimary interventionnegative111%-16%
REOMOBILE (Arntz), 2003   Abciximabprimary interventionnegative-8%-100%
Zorman, 2002     Abciximabprimary interventionnegative 45%-100%
ReoPro-BRIDGING (Gyongyosi), 2004     Abciximabprimary interventionnegative -52%
Bellandi, 2006     Abciximabprimary interventionnegative -48%4%
FINESSE (abciximab-facilitated PCI), 2008    NCTAbciximabprimary interventionnegative-17%23%
FINESSE (combination-facilitated PCI), 2008    NCTAbciximab + reteplaseprimary interventionnegative 81%16%

coronary artery disease  

Kim, 2010     abciximab-coated stentbare-metal stentExploratory -

percutaneous coronary intervention  

RAPPORT, 1998     Abciximabplacebo -
ADMIRAL, 2001     Abciximabplacebo -
CADILLAC, 2002     Abciximabplacebo -
EPIC (with infusion), 1994     Abciximabplacebo -
EPILOG, 1997     Abciximabplacebo -
EPISTENT, 1998         Abciximabplacebo -
CAPTURE, 1997     Abciximabplacebo -
ERASER, 1999     Abciximabplacebo -
Petronio, 2002     Abciximabplacebo -
Simoons, 1994   Abciximabplacebo -
Kini, 2001     Abciximabplacebo -
Tamburino, 2002   Abciximabplacebo -
ISAR-2, 2000     Abciximabplacebo -



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons